Marco Cattaneo, Elena M Bertinato, et al. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? Thromb Haemost. 2020 Apr 29. DOI: 10.1055/s-0040-1712097.
Francesco Catellani, Andrea Coscione, et al. Treatment of Proximal Femoral Fragility Fractures in Patients With COVID-19 During the SARS-CoV-2 Outbreak in Northern Italy. J Bone Joint Surg Am. 2020 Apr 28. DOI: 10.2106/JBJS.20.00617.
Jecko Thachil. The Versatile Heparin in COVID-19. J Thromb Haemost. 2020 May;18(5):1020-1022. DOI: 10.1111/jth.14821.
Ning Tang, Huan Bai, et al. Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. DOI: 10.1111/jth.14817.
Claire S Whyte, Gael B Morrow, et al. Fibrinolytic Abnormalities in Acute Respiratory Distress Syndrome (ARDS) and Versatility of Thrombolytic Drugs to Treat COVID-19. J Thromb Haemost. 2020 Apr 23. DOI: 10.1111/jth.14872.
Jecko Thachil, Ning Tang, et al. Type and Dose of Heparin in COVID-19. J Thromb Haemost. 2020 Apr 23. DOI: 10.1111/jth.14870.
F B Belen-Apak, F Sarialioglu. The Old but New: Can Unfractioned Heparin and Low Molecular Weight Heparins Inhibit Proteolytic Activation and Cellular Internalization of SARS-CoV2 by Inhibition of Host Cell Proteases? Med Hypotheses. 2020 Apr 20;142:109743. DOI: 10.1016/j.mehy.2020.109743.
Robert Beun, Nuray Kusadasi, et al. Thromboembolic Events and Apparent Heparin Resistance in Patients Infected With SARS-CoV-2. Int J Lab Hematol. 2020 Apr 20. DOI: 10.1111/ijlh.13230.
Christopher D Barrett, Hunter B Moore, et al. ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19: A Comment. J Thromb Haemost. 2020 Apr 17. DOI: 10.1111/jth.14860.
Hidesaku Asakura, Haruhiko Ogawa. Potential of Heparin and Nafamostat Combination Therapy for COVID-19. J Thromb Haemost. 2020 Apr 17. DOI: 10.1111/jth.14858.
Sophie Testa, Oriana Paoletti, et al. Switch From Oral Anticoagulants to Parenteral Heparin in SARS-CoV-2 Hospitalized Patients. Intern Emerg Med. 2020 Apr 15;1-3. DOI: 10.1007/s11739-020-02331-1.
Angelo Porfidia, Roberto Pola. Venous Thromboembolism in COVID-19 Patients. J Thromb Haemost. 2020 Apr 15. DOI: 10.1111/jth.14842.
Alessandro Casini, Lorenzo Alberio, et al. Thromboprophylaxis and Laboratory Monitoring for In-Hospital Patients With COVID-19 - A Swiss Consensus Statement by the Working Party Hemostasis. Swiss Med Wkly. 2020 Apr 11;150:w20247. DOI: 10.4414/smw.2020.20247.
Shiyu Yin, Ming Huang, et al. Difference of Coagulation Features Between Severe Pneumonia Induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020 Apr 3;1-4. DOI: 10.1007/s11239-020-02105-8.
